GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
The hormone progesterone is readily converted to 3alpha-OH-5alpha-pregnan-20-one (3alpha,5alpha-THP) in the brains of males and females. In the brain, 3alpha,5alpha-THP acts like a sedative, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (gamma-aminobutyric acid), the brain's major inhibitory neurotransmitter. Symptoms of premenstrual syndrome (PMS), such as anxiety and seizure susceptibility, are associated with sharp declines in circulating levels of progesterone and, consequently, of levels of 3alpha,5alpha-THP in the brain. Abrupt discontinuation of use of sedatives such as benzodiazepines and ethanol can also produce PMS-like withdrawal symptoms. Here we report a progesterone-withdrawal paradigm, designed to mimic PMS and post-partum syndrome in a rat model. In this model, withdrawal of progesterone leads to increased seizure susceptibility and insensitivity to benzodiazepine sedatives through an effect on gene transcription. Specifically, this effect was due to reduced levels of 3alpha,5alpha-THP which enhance transcription of the gene encoding the alpha4 subunit of the GABA(A) receptor. We also find that increased susceptibility to seizure after progesferone withdrawal is due to a sixfold decrease in the decay time for GABA currents and consequent decreased inhibitory function. Blockade of the alpha4 gene transcript prevents these withdrawal properties. PMS symptoms may therefore be attributable, in part, to alterations in expressio…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This effect involves a 6-fold decrease in the GABAA current time constant.”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
In the citing paper
“In a progesterone-withdrawal paradigm in the rat, mimicking post-menstrual and post-partum syndromes, reduced levels of allopregnanolone enhance the expression of GABAA α4 subunit, involving GABAA reduced activity [55].”
From Fibromyalgia pathogenesis explained by a neuroendocrine multistable model (2024) · cites this paper as [55]
Citations
Cites
Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor
Majewska, M. D., Harrison, N. L., Schwartz, R. D., Barker, J. L., & Paul, S. M. (1986) · Science · doi:10.1126/science.2422758 · Cited by 2,225 · cited 1×
“, decreasing anxiety and reducing seizure activity, by enhancing the function of GABA (γ-aminobutyric acid”
BackgroundPurdy, R. H., Morrow, A. L., Moore, P. H., & Paul, S. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.10.4553 · Cited by 951
Bitran, D., Hilvers, R. J., & Kellogg, C. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90761-j · Cited by 457
Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one
Belelli, D., Bolger, M. B., & Gee, K. W. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90077-0 · Cited by 323
Wafford, K. A., Thompson, S. A., Thomas, D., Sikela, J., Wilcox, A. S., & Whiting, P. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09339-3 · Cited by 268
Devaud, L. L., Fritschy, J., Sieghart, W., & Morrow, A. L. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69010126.x · Cited by 261
Cloning, pharmacological characteristics and expression pattern of the rat GABAA receptor α4 subunit
Wisden, W., Herb, A., Wieland, H., Keinänen, K., Lüddens, H., & Seeburg, P. H. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81076-k · Cited by 260
Twyman, R. E., & Macdonald, R. L. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019334 · Cited by 243
Bäckström, T., Zetterlund, B., Blom, S., & Romano, M. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07807.x · Cited by 242
The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors
Brot, M. D., Akwa, Y., Purdy, R. H., Koob, G. F., & Britton, K. T. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00096-4 · Cited by 234
Research works printed but not linked: 1
- Wafford, K. A. et al. Functional characterization of human GABA receptors containing the α4 subunit. Mol. Pharmacol. 50, 670–678 (1996).
Cited by
Items 501–561 of 561
Catamenial epilepsy: current concepts of definition, prevalence, pathophysiology and treatment
Herzog, A. G. (2015) · Clinical Epileptology · doi:10.1007/s10309-015-0005-6 · Cited by 4
Wihlbäck, A., Nyberg, S., Andersson, A., Bixo, M., Bäckström, T. C., & Poromaa, I. S. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701550015 · Cited by 2
“Also, based on animal studies on progesterone withdrawal we knew that significant changes in GABAA-receptor subunit composition and neurosteroid sensitivity would occur after 24 h of withdrawal [20,21].”
BackgroundRupprecht, R. (2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80030-6 · Cited by 3
Neuroactive Steroids and the GABAA Receptor
Smith, S. S., & Shen, H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00055-9 · Cited by 1
Self-citation(2005) · Steinkopff eBooks · doi:10.1007/3-7985-1556-5_3 · Cited by 1
Women’s Neurobiology and Well-being
Gordon, S. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-10059-8_6 · Cited by 1
Botanicals and Nutrition in the Treatment of Epilepsy
Elsas, S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374228-5.00005-6 · Cited by 1
Effects of neuroactive steroids on the recombinant GABAA receptor in Xenopus oocyte
Rahman, M. (2007) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 1
The hormone withdrawal hypothesis of postpartum depression: a translational approach
Schiller, C. E. (2011) · doi:10.17077/etd.xz9u2d8q · Cited by 4
“Progesterone metabolites have been shown to act as a sedative, decreasing anxiety by enhancing GABA function (Smith et al., 1998).”
BackgroundRibozyme-mediated reduction of the GABAA receptor α1 subunit
Subramaniam, J. R., Corsi, L., Vicini, S., Whiting, P. J., & Neale, J. H. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00167-x · Cited by 1
Neuroactive steroids and rat CNS
Birzniece, V. (2004) · DiVA at Umeå University (Umeå University) · Cited by 1
Behavioral effects of female sex steroid hormones : models of PMS and PMDD in Wistar rats
Löfgren, M. (2009) · DiVA at Umeå University (Umeå University) · Cited by 2
Impact of Neuroendocrine Factors on Seizure Genesis and Treatment
Klein, P. (2004) · doi:10.3109/9780203021934-24 · Cited by 1
Ovarian Steroid Hormones, Emotion Processing and Mood
Gingnell, M. (2013) · Uppsala University Publications (Uppsala University) · Cited by 2
Rapkin, A. J., & Mikacich, J. A. (2006) · Springer eBooks · doi:10.1007/978-3-540-29805-2_3501 · Cited by 1
Genazzani, A. R., Bernardi, F., Liut, M., Stomati, M., Pieri, M., & Luisi, M. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1061-1_32 · Cited by 1
Zhao, T.-J., Li, M., Chiu, T. H., & Rosenberg, H. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37853-x · Cited by 1
“More recently, Smith et al. (1998) showed that pretreating rats with an ASO against the alpha-4 subunit of the GABAA receptor prevented the increased seizure susceptibility observed after progesterone withdrawal, which was apparently related to an increase in alpha-4 expression.”
GABA | Mechanisms of GABAA Receptor Gene Regulation in Epilepsy
Lund, I. V., Hu, Y., Russek, S. J., & Brooks‐Kayal, A. R. (2009) · Elsevier eBooks · doi:10.1016/b978-012373961-2.00035-7 · Cited by 1
Kim, H. Y., & Olsen, R. W. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56833-6_9 · Cited by 2
The Use of Antisense Technologies to Understand Neural Functioning: Fact or Fiction?
McCarthy, M. M. (1998) · Perspectives in antisense science · doi:10.1007/978-1-4615-4933-8_1
Kask, K. (2008) · Uppsala University Publications (Uppsala University)
Anxiety Disorders: Macromolecular Pathways and Interactions
Tóth, M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb665
Effects of progesterone or neuroactive steroid?
Smith, S. S., Gong, Q. H., Hsu, F., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X. (1998) · Nature · doi:10.1038/27109
Self-citationNeuroactive Steroids and the GABAA Receptor
Smith, S. S., & Shen, H. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00047-4
Self-citationNeuroactive Steroids in Brain and Relevance to Mood
Bückström, T., Andréen, L., Bixo, M., Björn, I., Fernández, G., Johansson, I., Lundgren, P., Löfgren, M., Nyberg, S., Ragagnin, G., et al. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_20 · Cited by 2
Extrasynaptic GABA Type A Receptors in the Mechanism of Action of Ethanol
Chandra, D. (2008) · D-Scholarship@Pitt (University of Pittsburgh)
Neurosteroid effects on GABA‐A receptor subunit composition
Smith, Gong, Li, & Markowitz (1999) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1999.0600b.x
Neurosteroids in clinical practice: implications for women’s health
Genazzani, A. R., Bucci, F., Russo, N., Daino, D., Santoro, A. N., & Pluchino, N. (2011) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2011.120
Interactions between glucocorticoid metabolism and inflammation in obesity and insulin resistance.
Nixon, M. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Catamenial Epilepsy: A Bizarre phenomenon!
Khardenavis, V. J., Khardenavis, V., & Deshpande, A. (2014) · Molecular & Cellular Epilepsy · doi:10.14800/mce.241
“Lamotrigine, Hormonal therapy in the form of natural and/or medroxy progesterone, clomiphene citrate, oral contraceptive pills, Gonadotropin releasing hormone (GnRH) analogues Triptorelin have also been tried with limited success in Catamenial epilepsy [26-30] .”
BackgroundZhao, T.-J., Li, M., Chiu, T. H., & Rosenberg, H. C. (1998)
Estrogen and Androgen: Mood, Sexual Function, and Quality of Life in the Menopausal Woman
Alexander, J. L., Kotz, K. J., & Davis, S. R. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1061-1_34
Hanley, C. (2015) · ORCA Online Research @Cardiff (Cardiff University)
Role of Neurosteroids in Epilepsy
Mtchedlishvili, Z., & Kapur, J. (2003) · Frontiers in neuroscience · doi:10.1201/9780203508169.ch14
Modulators of the GABAA receptor: novel therapeutic prospects
Thomsen, C., & Ebert, B. (2001) · CRC Press eBooks · doi:10.1201/9780203299388-26 · Cited by 2
Chaiworakul, V., Kosonsiriluk, S., Mauro, L. J., & Halawani, M. E. E. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.10.002
Chapter 20 Neuroactive Steroids in Brain and Relevance to Mood
Bäckström, T. C., Andréen, L., Bixo, M., Björn, I., Johansson, I., Lundgren, P., Löfgren, M., Ragagnin, G., Poromaa-Sundström, I., Strömberg, J., et al. (2008)
Review article Premenstrual dysphoric disorder and psychiatric co-morbidity
Kim, D. R., Gyulai, L., Freeman, E. W., Morrison, M. F., Baldassano, C. F., & Dubé, B. (2004)
Studies on Premenstrual Dysphoria
Eriksson, O. (2005) · Uppsala University Publications (Uppsala University)
Perimenstrual Seizures and Neurosteroid Withdrawal
Reddy, D. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804066-9.00063-8
Brasilino, L. S. B. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.59.2017.tde-11092017-221909
Neurosteroid: Molecular Mechanisms of Action on the GABAA Receptor
Wang, M., Rahman, M., Strömberg, J., Lundgren, P., Haage, D., Johansson, I., & Bückström, T. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6854-6_1
A Study on the Prevalence of Catamenial Epilepsy: An Elusive Condition
Kavitha, M. (2014)
Early Development of Dietary Supplements for Preventing Postpartum Depression
Dowlati, Y. (2015) · TSpace (University of Toronto)
Endogenous and Synthetic Neurosteroids in the Treatment of Niemann–Pick Type C Disease
Mellon, S. H., Gong, W., & Schonemann, M. D. (2011) · Wiley eBooks · doi:10.1002/9783527633968.ch4
Tóth, M. (2012) · Wiley eBooks · doi:10.1002/9781118435762.ch12
The menstrual cycle and catamenial epilepsy
Herzog, A. G. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511921001.092
Molecular mechanisms of tolerance to and withdrawal of GABAA receptor modulators
Biggio, G. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)90001-0
Papadeas, S. T., Grobin, A. C., & Morrow, A. L. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1097/00000374-200109000-00005
Impact of Neuroendocrine Factors on Seizure Genesis and Treatment
Klein, P., & Janouŝek, J. (2010) · Epilepsy · doi:10.1201/9781420085594-c27 · Cited by 1
Mechanisms of GABAA Receptor Gene Regulation in Epilepsy☆
Cogswell, M., Russek, S. J., & Brooks‐Kayal, A. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.00049-3
Neuroendocrine Regulation of Anxiety
Onisiforou, A., Zanos, P., & Georgiou, P. (2024) · Springer eBooks · doi:10.1007/978-3-031-56798-8_3
Safe Deprescribing of Benzodiazepines and Z‐drugs
(2024) · Wiley eBooks · doi:10.1002/9781394291052.mdg003
Rajasekaran, K., Mtchedlishvili, Z., Sun, C., & Kapur, J. (2009) · Elsevier eBooks · doi:10.1016/b978-012373961-2.00104-1
Lanczik, M., Kersting, A., Hornstein, C., & Klier, C. M. (2002) · Springer eBooks · doi:10.1007/978-3-642-59394-9_11
Reid, M. J., Coon, W. G., Altier, H. R., Antonsdottir, I. M., Hamilton, K. R., Kim-Dahl, A., Maybrier, H. R., Nilsson, S. J., Nakad, L., Wendler, K., et al. (2026) · SLEEP · doi:10.1093/sleep/zsag141
HORMONAL MODULATION OF THE BEHAVIORAL EFFECTS OF TRAIZOLAM
Babalonis, S. L. (2010) · UKnowledge (University of Kentucky)
Earl, D. E. (2011) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Metadata
- Authors
- Smith, S. S., Gong, Q. H., Hsu, F.-C., Markowitz, R. S., ffrench-Mullen, J. M. H., & Li, X.
- Corresponding author
- Smith, Sheryl S.
- ORCID
- Smith, Sheryl S.
- Venue
- Nature
- Published
- 1998-04
- Volume
- 392
- Issue
- 6679
- Pages
- 926-929
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1647312149
- Semantic Scholar
- 3539e8269bee3fd116e338cc540f9de8e78942b1
- Cited by
- 564
- References
- 31
- Citations by year
- 2026: 1 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 16 · 2015: 14 · 2014: 16 · 2013: 21 · 2012: 20
- FWCI
- 17.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- progesterone withdrawal, 3alpha,5alpha-THP, premenstrual syndrome, seizure susceptibility, GABA currents, gene transcription, steroid hormones, anxiety, GABAergic inhibition
- MeSH terms
- Animals, Azides, Benzodiazepines, Carbolines, Female, gamma-Aminobutyric Acid, Hippocampus, Indomethacin, Lorazepam, Pregnanolone, Premenstrual Syndrome, Progesterone, Receptors, GABA-A, RNA, Messenger, Anti-Anxiety Agents, Transcription, Genetic, Oligonucleotides, Antisense, Pyramidal Cells, Patch-Clamp Techniques, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.